Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III lot-consistency and comparator study of Hib-MenCY-TT vaccine in healthy infants
2005-002352-18Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Haemophilus influenzae type b and meningococcal vaccine in Haemophilus influenzae type b disease (Hib), meningococcal group C disease, meningococcal disease and 1 more (4 arms), sponsored by GSK. Primary endpoint: Anti-PRP antibody concentrations.
02
Drugs
Haemophilus influenzae type b and meningococcal vaccine
03
Conditions
Haemophilus influenzae type b disease (Hib)meningococcal group C diseasemeningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on 2005-002352-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002352-18.